These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 35515502)

  • 1. The Impact of Corporate Capital Structure on Financial Performance Based on Convolutional Neural Network.
    Luo Y; Jiang C
    Comput Intell Neurosci; 2022; 2022():5895560. PubMed ID: 35515502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Inhibitory Effect of the Deregulation Short-Sale on Private Equity Placement.
    Wang P; Su C; Xu B
    Front Psychol; 2022; 13():888805. PubMed ID: 35903744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial Management of Listed Companies Based on Convolutional Neural Network Model in the Context of Epidemic.
    Duan Q; Cao X; Xu L
    Comput Intell Neurosci; 2022; 2022():1871315. PubMed ID: 36164427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive pharmaceutical background, R&D investment and corporate innovation performance.
    Zhang L; Li S; Wu M
    Am J Transl Res; 2023; 15(11):6576-6586. PubMed ID: 38074834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between Enterprise Financing Structure and Business Performance Assisted by Blockchain for Internet of Things Financing Mode.
    Li J; Feng H; Li M; Li M; Chen Y
    Comput Intell Neurosci; 2022; 2022():2076830. PubMed ID: 35685158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does CSR affect the cost of equity capital: Empirical evidence from the targeted poverty alleviation of listed companies in China.
    Yi Y; Xie B; Zhou L; Wei Y
    PLoS One; 2020; 15(2):e0227952. PubMed ID: 32032381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Equity Disputes in Listed Companies With Dispersed Ownership Structure and Protection of Small and Medium Shareholders' Interests.
    He CX; Soh WN; Ong TS; Lau WT; Zhong B
    Front Psychol; 2022; 13():857585. PubMed ID: 35668972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cost-benefit analysis under back propagation neural network on financial benefit evaluation of investment projects.
    Zhong Y; Wu X
    PLoS One; 2020; 15(3):e0229739. PubMed ID: 32134951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of voluntary disclosure on financial performance: Empirical study on manufacturing industry in Indonesia.
    Meiryani ; Huang SM; Soepriyanto G; Jessica ; Fahlevi M; Grabowska S; Aljuaid M
    PLoS One; 2023; 18(6):e0285720. PubMed ID: 37267373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring and Analysis of Venture Capital and Corporate Fraud Based on Deep Learning.
    Zhang R; Zheng L
    Comput Intell Neurosci; 2022; 2022():4589593. PubMed ID: 35685167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Governance of non-state-owned shareholders and corporate capital structure decision: A mechanism test from the opportunistic behavior of management.
    Wang J; Hu Y; Liao F; Xu S
    PLoS One; 2023; 18(1):e0281120. PubMed ID: 36706148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nexus of the CSR disclosures and corporate financial performance: evidence from Asian countries climate policy uncertainty.
    Waris M; Din BH
    Environ Sci Pollut Res Int; 2024 Jan; 31(2):1995-2008. PubMed ID: 38049691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corporate capital structure effects on corporate performance pursuing a strategy of innovation in manufacturing companies.
    Ahmed F; Rahman MU; Rehman HM; Imran M; Dunay A; Hossain MB
    Heliyon; 2024 Feb; 10(3):e24677. PubMed ID: 38322932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term and short-term effects of green strategy on corporate performance: evidence from Chinese listed companies.
    Yu W; Jin X
    Environ Sci Pollut Res Int; 2022 Apr; 29(16):24112-24130. PubMed ID: 34822093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental, social, and governance information disclosure and stock price crash risk: Evidence from Chinese listed companies.
    Xu N; Liu J; Dou H
    Front Psychol; 2022; 13():977369. PubMed ID: 36204747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of China's Vaccine Incidents on the Operational Efficiency of Biopharmaceutical Companies.
    Chai KC; Tao R; Chang KC; Yang Y
    Front Public Health; 2020; 8():93. PubMed ID: 32322567
    [No Abstract]   [Full Text] [Related]  

  • 17. On the fast track: the benefits of ESG performance on the commercial credit financing.
    Huang Y; Bai F; Shang M; Ahmad M
    Environ Sci Pollut Res Int; 2023 Jul; 30(35):83961-83974. PubMed ID: 37351751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
    Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB
    Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indicators From China's Listed Corporations on Corporate Financing Behavior and Policy-Related Risk.
    Zhang W; Ausaf MA; Jahangir J
    Front Psychol; 2022; 13():930929. PubMed ID: 36059743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on Conditional Conservatism Within Fair Value Measurements Based on Anti-discount Expectations.
    Yu Q; Guo J; Ding L; Hu Q
    Front Psychol; 2022; 13():923055. PubMed ID: 35865680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.